Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-19

FDA Approved: CERETEC — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)

View source ↗

Summary

FDA approved a supplemental application for CERETEC (technetium-99m exametazime), a radiopharmaceutical imaging agent, to modify/expand its labeling. The produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CERETEC (TECHNETIUM TC-99M EXAMETAZIME; TECHNETIUM TC-99M EXAMETAZIME AND COBALTOUS CHLORIDE)

Snippet

SUPPL AP for CERETEC (TECHNETIUM TC-99M EXAMETAZIME)